ADIL
Adial Pharmaceuticals Inc
Halal Rating :
Last Price
$1.00
Last updated:
Market Cap
-
7D Change
-0.99%
1 Year Change
-23.55%
Company Overview
Industries
Exchange
Next Earnings Date
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medications for the treatment of alcohol use disorder (AUD) and other addictive disorders. Their lead investigational drug candidate is AD04, which targets alcohol use disorder in patients with certain genetic markers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Adial Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.